首页 > 最新文献

Cvd Prevention and Control最新文献

英文 中文
Thai Acute Decompensated Heart Failure Registry (Thai ADHERE) 泰国急性失代偿性心力衰竭登记(泰国坚持)
Pub Date : 2010-09-01 DOI: 10.1016/j.cvdpc.2010.06.001
Prasart Laothavorn , Kriengkrai Hengrussamee , Rungsrit Kanjanavanit , Worachat Moleerergpoom , Donpichit Laorakpongse , Orathai Pachirat , Smonporn Boonyaratavej , Piyamitr Sritara , On behalf of Thai ADHERE Registry working groups

Background

Heart Failure (HF) is the one of the malignant cardiac syndromes which has a high morbidity and mortality rate. In Thailand, HF is one of the major cardiovascular health problems and economic burdens disease. Thai ADHERE is the first HF registry in Thailand.

Objective

To assess patient with HF in Thailand in terms of patients’ characteristics, clinical presentation, causes of heart failure, and precipitating causes of heart failure, hospital course, management, and in-hospital outcomes.

Material and methods

Thai Acute Decompensated Heart Failure Registry or Thai ADHERE registry is a Phase IV, multicenter, observational, and open-label registry in 18 cardiac centers in Thailand using the US ADHERE protocol. Medical records of hospitalized patients with the principal discharge diagnosis of HF from March 2006 to November 2007 were validated and registered via an electronic web based system.

Results

There were 2041 HF admissions in 1612 patients with a median age of 67 years (mean 64 ± 14 years). Age >75 years was found in 24%, 49.6% were male patients, and 67% of these admissions had prior heart failure. Underlying diseases were hypertension [(HT) = 65%], coronary artery disease [(CAD) = 47%], dyslipidemia (50%), diabetes mellitus (47%), atrial fibrillation (24%) and chronic kidney disease (19%). Clinical features at presentation were dyspnea (97%), edema (60%), pulmonary rales (85%) and pulmonary congestion by chest X-ray (93%). Sixty-nine percent (69%) were in NYHA functional class IV and 44% had a left ventricular ejection fraction (LVEF) less than 40%. Common causes of heart failure were CAD (45%), valvular heart diseases (19%), cardiomyopathy (14%) and HT (12%). Precipitating causes of heart failure were heart disease itself 54% and 20% were related to inadequate diuretics and poor patient compliance with medications. Neurohormonal blockers (NHB) [angiotensin converting enzyme inhibitors (ACEI), angiotensinoge receptor blocker (ARB), aldosterone blocker (AA) and beta blockers (BB)], were given prior to hospitalization in comparison to at discharge in 26% vs. 35%, 12% vs. 12%, 13% vs. 17% and 26% vs. 24% respectively. In-hospital mortality rate was 5.5% and the median length of hospitalization was 7.5 days. Major causes of death were sepsis, worsening of heart failure, arrhythmic arrest and acute coronary syndrome. There was a higher mortality rate in those with poor LV systolic function compared to those with preserved LV systolic function (8.2% vs. 4.1%; p = .008). At discharge, 23% of the patients were asymptomatic while 69% had symptomatic improvement.

Conclusion

Thai ADHERE registry revealed that Thai patients hospitalized for heart failure are younger and sicker than European and American p

背景心力衰竭(HF)是一种发病率和死亡率都很高的恶性心脏综合征。在泰国,心衰是主要的心血管健康问题和经济负担疾病之一。泰国坚持是第一个HF登记在泰国。目的评估泰国心力衰竭患者的特点、临床表现、心力衰竭的原因和诱发心力衰竭的原因、住院过程、管理和住院结果。材料和方法泰国急性失代偿性心力衰竭注册(Thai Acute decom代偿性心力衰竭Registry)是泰国18个心脏中心采用美国依从方案的4期、多中心、观察性和开放标签注册。对2006年3月至2007年11月出院诊断为心衰的住院患者的病历进行验证,并通过基于电子网络的系统进行登记。结果1612例HF患者入院2041例,中位年龄67岁(平均64±14岁)。年龄在75岁的患者占24%,其中49.6%为男性,其中67%有心力衰竭病史。基础疾病为高血压(HT) = 65%,冠心病(CAD) = 47%,血脂异常(50%),糖尿病(47%),房颤(24%),慢性肾病(19%)。临床表现为呼吸困难(97%),水肿(60%),肺部啰音(85%)和胸部x线肺部充血(93%)。69%的患者为NYHA功能IV级,44%的患者左室射血分数(LVEF)小于40%。心力衰竭的常见原因是CAD(45%)、瓣膜性心脏病(19%)、心肌病(14%)和HT(12%)。心力衰竭的促发原因是心脏病本身,54%和20%与利尿剂不足和患者服药依从性差有关。与出院时相比,住院前给予神经激素阻滞剂(NHB)[血管紧张素转换酶抑制剂(ACEI)、血管紧张素受体阻滞剂(ARB)、醛固酮阻滞剂(AA)和β受体阻滞剂(BB)]的比例分别为26%对35%、12%对12%、13%对17%和26%对24%。住院死亡率为5.5%,中位住院时间为7.5天。主要死亡原因为败血症、心力衰竭加重、心律失常和急性冠状动脉综合征。左室收缩功能差的患者死亡率高于左室收缩功能保存的患者(8.2% vs. 4.1%;p = .008)。出院时,23%的患者无症状,69%的患者症状改善。结论泰国依从登记显示泰国因心力衰竭住院的患者比欧洲和美国患者更年轻,病情更重。有较高的流行HF与保留射血分数。冠心病是HF最常见的病因,而HT是最常见的基础疾病。死亡率为5.4%,左室收缩功能差的患者死亡率更高。NHB (ACEI、ARB、BB和AA)利用不足。
{"title":"Thai Acute Decompensated Heart Failure Registry (Thai ADHERE)","authors":"Prasart Laothavorn ,&nbsp;Kriengkrai Hengrussamee ,&nbsp;Rungsrit Kanjanavanit ,&nbsp;Worachat Moleerergpoom ,&nbsp;Donpichit Laorakpongse ,&nbsp;Orathai Pachirat ,&nbsp;Smonporn Boonyaratavej ,&nbsp;Piyamitr Sritara ,&nbsp;On behalf of Thai ADHERE Registry working groups","doi":"10.1016/j.cvdpc.2010.06.001","DOIUrl":"10.1016/j.cvdpc.2010.06.001","url":null,"abstract":"<div><h3>Background</h3><p>Heart Failure (HF) is the one of the malignant cardiac syndromes which has a high morbidity and mortality rate. In Thailand, HF is one of the major cardiovascular health problems and economic burdens disease. Thai ADHERE is the first HF registry in Thailand.</p></div><div><h3>Objective</h3><p>To assess patient with HF in Thailand in terms of patients’ characteristics, clinical presentation, causes of heart failure, and precipitating causes of heart failure, hospital course, management, and in-hospital outcomes.</p></div><div><h3>Material and methods</h3><p>Thai Acute Decompensated Heart Failure Registry or Thai ADHERE registry is a Phase IV, multicenter, observational, and open-label registry in 18 cardiac centers in Thailand using the US ADHERE protocol. Medical records of hospitalized patients with the principal discharge diagnosis of HF from March 2006 to November 2007 were validated and registered via an electronic web based system.</p></div><div><h3>Results</h3><p>There were 2041 HF admissions in 1612 patients with a median age of 67<!--> <!-->years (mean 64<!--> <!-->±<!--> <!-->14<!--> <!-->years). Age &gt;75<!--> <!-->years was found in 24%, 49.6% were male patients, and 67% of these admissions had prior heart failure. Underlying diseases were hypertension [(HT)<!--> <!-->=<!--> <!-->65%], coronary artery disease [(CAD)<!--> <!-->=<!--> <!-->47%], dyslipidemia (50%), diabetes mellitus (47%), atrial fibrillation (24%) and chronic kidney disease (19%). Clinical features at presentation were dyspnea (97%), edema (60%), pulmonary rales (85%) and pulmonary congestion by chest X-ray (93%). Sixty-nine percent (69%) were in NYHA functional class IV and 44% had a left ventricular ejection fraction (LVEF) less than 40%. Common causes of heart failure were CAD (45%), valvular heart diseases (19%), cardiomyopathy (14%) and HT (12%). Precipitating causes of heart failure were heart disease itself 54% and 20% were related to inadequate diuretics and poor patient compliance with medications. Neurohormonal blockers (NHB) [angiotensin converting enzyme inhibitors (ACEI), angiotensinoge receptor blocker (ARB), aldosterone blocker (AA) and beta blockers (BB)], were given prior to hospitalization in comparison to at discharge in 26% vs. 35%, 12% vs. 12%, 13% vs. 17% and 26% vs. 24% respectively. In-hospital mortality rate was 5.5% and the median length of hospitalization was 7.5<!--> <!-->days. Major causes of death were sepsis, worsening of heart failure, arrhythmic arrest and acute coronary syndrome. There was a higher mortality rate in those with poor LV systolic function compared to those with preserved LV systolic function (8.2% vs. 4.1%; <em>p</em> <!-->=<!--> <!-->.008). At discharge, 23% of the patients were asymptomatic while 69% had symptomatic improvement.</p></div><div><h3>Conclusion</h3><p>Thai ADHERE registry revealed that Thai patients hospitalized for heart failure are younger and sicker than European and American p","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 3","pages":"Pages 89-95"},"PeriodicalIF":0.0,"publicationDate":"2010-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2010.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79985439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 45
Picture my heart: Reflections on cardiovascular care in developing countries 描绘我的心:对发展中国家心血管护理的思考
Pub Date : 2010-06-01 DOI: 10.1016/j.cvdpc.2010.04.006
A.Y.Y. Fong, K.H. Sim
{"title":"Picture my heart: Reflections on cardiovascular care in developing countries","authors":"A.Y.Y. Fong,&nbsp;K.H. Sim","doi":"10.1016/j.cvdpc.2010.04.006","DOIUrl":"10.1016/j.cvdpc.2010.04.006","url":null,"abstract":"","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 2","pages":"Pages 63-64"},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2010.04.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78300217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Leukocytes are the major target of hepatitis C virus infection: Possible mechanism of multiorgan involvement including the heart 白细胞是丙型肝炎病毒感染的主要目标:包括心脏在内的多器官累及的可能机制
Pub Date : 2010-06-01 DOI: 10.1016/j.cvdpc.2010.04.005
Akira Matsumori , Miho Shimada , Tsutomu Obata

Chronic hepatitis C virus infection has been associated with several extrahepatic manifestations, among these, renal and cardiac involvement. However, morphological evidence of hepatitis C virus localization in various organs remains to be clarified.

We used immunohistochemistry to analyze the hepatitis C virus core and nonstructural antigens. Peripheral blood mononuclear cells were obtained from four patients with hepatitis C virus infection. Liver, kidney, heart, and bone marrow were taken from autopsy specimens from nine patients with hepatocellular carcinoma and three patients with cardiomyopathies with positive hepatitis C virus infection.

Antibody against hepatitis C virus core antigen stained peripheral blood mononuclear cells, and the majority of positive staining was seen in CD68-positive macrophages. Hepatitis C virus core and NS4 antibodies stained mostly infiltrating cells in the liver, heart, kidney, and bone marrow, but not hepatocytes, myocytes, or globular cells. Serial sections stained by CD68, CD3, and CD20 antibodies showed that most of the hepatitis C virus-positive cells were CD68-positive macrophages.

We demonstrate for the first time clear distribution of hepatitis C virus antigen in mononuclear cells in various organs from patients with hepatitis C virus infection. This study suggests that macrophages are the major target of hepatitis C virus infection.

慢性丙型肝炎病毒感染与几种肝外表现有关,其中包括肾脏和心脏受累。然而,丙型肝炎病毒在各个器官定位的形态学证据仍有待澄清。我们使用免疫组织化学分析丙型肝炎病毒核心抗原和非结构抗原。本文采集了4例丙型肝炎病毒感染患者外周血单个核细胞。从9例肝细胞癌患者和3例丙型肝炎病毒感染阳性的心肌病患者的尸检标本中取肝、肾、心和骨髓。外周血单核细胞可见抗丙型肝炎病毒核心抗原抗体染色,cd68阳性巨噬细胞以阳性染色居多。丙型肝炎病毒核心抗体和NS4抗体染色的主要是肝、心、肾和骨髓浸润细胞,而不是肝细胞、肌细胞或球状细胞。CD68、CD3和CD20抗体连续切片显示,大多数丙型肝炎病毒阳性细胞为CD68阳性巨噬细胞。我们首次证明丙型肝炎病毒抗原在丙型肝炎病毒感染患者各器官的单核细胞中明确分布。本研究提示巨噬细胞是丙型肝炎病毒感染的主要靶点。
{"title":"Leukocytes are the major target of hepatitis C virus infection: Possible mechanism of multiorgan involvement including the heart","authors":"Akira Matsumori ,&nbsp;Miho Shimada ,&nbsp;Tsutomu Obata","doi":"10.1016/j.cvdpc.2010.04.005","DOIUrl":"10.1016/j.cvdpc.2010.04.005","url":null,"abstract":"<div><p>Chronic hepatitis C virus infection has been associated with several extrahepatic manifestations, among these, renal and cardiac involvement. However, morphological evidence of hepatitis C virus localization in various organs remains to be clarified.</p><p>We used immunohistochemistry to analyze the hepatitis C virus core and nonstructural antigens. Peripheral blood mononuclear cells were obtained from four patients with hepatitis C virus infection. Liver, kidney, heart, and bone marrow were taken from autopsy specimens from nine patients with hepatocellular carcinoma and three patients with cardiomyopathies with positive hepatitis C virus infection.</p><p>Antibody against hepatitis C virus core antigen stained peripheral blood mononuclear cells, and the majority of positive staining was seen in CD68-positive macrophages. Hepatitis C virus core and NS4 antibodies stained mostly infiltrating cells in the liver, heart, kidney, and bone marrow, but not hepatocytes, myocytes, or globular cells. Serial sections stained by CD68, CD3, and CD20 antibodies showed that most of the hepatitis C virus-positive cells were CD68-positive macrophages.</p><p>We demonstrate for the first time clear distribution of hepatitis C virus antigen in mononuclear cells in various organs from patients with hepatitis C virus infection. This study suggests that macrophages are the major target of hepatitis C virus infection.</p></div>","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 2","pages":"Pages 51-58"},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2010.04.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76968092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
The effect of hypertension, aging and benidipine on arterial elasticity in elderly hypertensives 高血压、衰老及苯尼地平对老年高血压患者动脉弹性的影响
Pub Date : 2010-06-01 DOI: 10.1016/j.cvdpc.2010.04.004
Tetsuhiro Umeno , Toshio Shimada , Hironori Tsukihashi , Nobuyuki Oyake , Yo Murakami , Nobuyuki Takahashi , Kazuaki Tanabe , Osamu Doi , Hirofumi Kambara , Akira Matsumori

Four hundred and 16 subjects (average age, 56.2 years; range, 20–92 years; Men/Women, 207/209) undergoing annual health check-up were studied for the effect of aging and hypertension on arterial compliance or elasticity index, which were measured after a 10 min rest in the supine position using CR-2000. Thirteen additional elderly patients with hypertension were also studied at rest in the supine position 30 min before and after 8 mg benidipine oral administration at the beginning of treatment and then repeatedly studied after a 10 min rest over at least 4–7 weeks to examine the effect of benidipine hydrochloride 8 mg on arterial compliance in a similar manner. Systolic blood pressure and pulse pressure were increased in subjects above 40 years of age. Diastolic blood pressure was also increased up to 60 years of age but after 60 years of age, it was decreased or rather it plateaued. Above 40 years of age, large and small arterial compliance levels were significantly decreased with advancing age. Small arterial compliance was much more decreased than large arterial compliance. In hypertensive subjects, small and large arterial compliance levels were significantly decreased in comparison with normotensive subjects. Benidipine hydrochloride 8 mg was given orally every morning in elderly hypertensive patients for at least 1 month, and blood pressure and arterial compliance were measured every week using CR-2000. Benidipine hydrochloride decreased blood pressure and improved arterial compliance gradually and safely without any adverse effect. Therefore, benidipine hydrochloride is thought to be a useful antihypertensive drug for elderly hypertensives because of its potential to improve arterial function and perhaps arterial properties.

416例,平均年龄56.2岁;范围:20-92年;研究了每年体检的男性/女性(207/209)年龄和高血压对动脉顺应性或弹性指数的影响,在仰卧位休息10分钟后用CR-2000测量动脉顺应性或弹性指数。另外13例老年高血压患者在治疗开始时口服苯地平8mg前后30分钟仰卧休息,然后在休息10分钟后重复研究至少4-7周,以类似的方式检查盐酸苯地平8mg对动脉依从性的影响。40岁以上受试者的收缩压和脉压升高。舒张压在60岁之前也是升高的但60岁之后,它就下降了,或者说是稳定了。40岁以上大、小动脉顺应性水平随年龄增长明显降低。小动脉顺应性比大动脉顺应性降低得多。在高血压患者中,小动脉和大动脉顺应性水平与正常患者相比显著降低。老年高血压患者每日晨起口服盐酸苯尼地平8mg,疗程至少1个月,每周用CR-2000检测血压和动脉顺应性。盐酸苯地平逐渐安全降低血压,改善动脉顺应性,无不良反应。因此,盐酸苯地平被认为是一种有用的抗高血压药物,因为它有可能改善动脉功能和动脉特性。
{"title":"The effect of hypertension, aging and benidipine on arterial elasticity in elderly hypertensives","authors":"Tetsuhiro Umeno ,&nbsp;Toshio Shimada ,&nbsp;Hironori Tsukihashi ,&nbsp;Nobuyuki Oyake ,&nbsp;Yo Murakami ,&nbsp;Nobuyuki Takahashi ,&nbsp;Kazuaki Tanabe ,&nbsp;Osamu Doi ,&nbsp;Hirofumi Kambara ,&nbsp;Akira Matsumori","doi":"10.1016/j.cvdpc.2010.04.004","DOIUrl":"10.1016/j.cvdpc.2010.04.004","url":null,"abstract":"<div><p>Four hundred and 16 subjects (average age, 56.2<!--> <!-->years; range, 20–92<!--> <!-->years; Men/Women, 207/209) undergoing annual health check-up were studied for the effect of aging and hypertension on arterial compliance or elasticity index, which were measured after a 10<!--> <!-->min rest in the supine position using CR-2000. Thirteen additional elderly patients with hypertension were also studied at rest in the supine position 30<!--> <!-->min before and after 8<!--> <!-->mg benidipine oral administration at the beginning of treatment and then repeatedly studied after a 10<!--> <!-->min rest over at least 4–7<!--> <!-->weeks to examine the effect of benidipine hydrochloride 8<!--> <!-->mg on arterial compliance in a similar manner. Systolic blood pressure and pulse pressure were increased in subjects above 40<!--> <!-->years of age. Diastolic blood pressure was also increased up to 60<!--> <!-->years of age but after 60<!--> <!-->years of age, it was decreased or rather it plateaued. Above 40<!--> <!-->years of age, large and small arterial compliance levels were significantly decreased with advancing age. Small arterial compliance was much more decreased than large arterial compliance. In hypertensive subjects, small and large arterial compliance levels were significantly decreased in comparison with normotensive subjects. Benidipine hydrochloride 8<!--> <!-->mg was given orally every morning in elderly hypertensive patients for at least 1<!--> <!-->month, and blood pressure and arterial compliance were measured every week using CR-2000. Benidipine hydrochloride decreased blood pressure and improved arterial compliance gradually and safely without any adverse effect. Therefore, benidipine hydrochloride is thought to be a useful antihypertensive drug for elderly hypertensives because of its potential to improve arterial function and perhaps arterial properties.</p></div>","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 2","pages":"Pages 45-50"},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2010.04.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74892684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Metabolic obesity: A new therapeutic target for cardio-metabolic risk reduction 代谢性肥胖:降低心脏代谢风险的新治疗靶点
Pub Date : 2010-06-01 DOI: 10.1016/j.cvdpc.2010.05.002
P.C. Manoria , Pankaj Manoria , Piyush Manoria

During the last couple of years, the focus of attention has drifted from coronary risk to cardio-metabolic risk because of the growing epidemic of cardio-metabolic disorders such as obesity, metabolic syndrome, diabetes, and cardiovascular disease (CVD). Physical inactivity and consumption of high-energy foods are the root causes of this epidemic.

在过去的几年中,由于心脏代谢疾病如肥胖、代谢综合征、糖尿病和心血管疾病(CVD)的日益流行,关注的焦点已经从冠状动脉风险转移到心脏代谢风险。缺乏身体活动和食用高能量食物是这一流行病的根源。
{"title":"Metabolic obesity: A new therapeutic target for cardio-metabolic risk reduction","authors":"P.C. Manoria ,&nbsp;Pankaj Manoria ,&nbsp;Piyush Manoria","doi":"10.1016/j.cvdpc.2010.05.002","DOIUrl":"10.1016/j.cvdpc.2010.05.002","url":null,"abstract":"<div><p>During the last couple of years, the focus of attention has drifted from coronary risk to cardio-metabolic risk because of the growing epidemic of cardio-metabolic disorders such as obesity, metabolic syndrome, diabetes, and cardiovascular disease (CVD). Physical inactivity and consumption of high-energy foods are the root causes of this epidemic.</p></div>","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 2","pages":"Pages 39-44"},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2010.05.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79914535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Metabolic syndrome and cardiovascular risk in diabetic subjects 糖尿病受试者的代谢综合征和心血管风险
Pub Date : 2010-06-01 DOI: 10.1016/j.cvdpc.2010.05.001
Faria Afsana, Zafar A. Latif, Shah J. Khan, Samir K. Talukder

There are divergent criteria for the identification of metabolic syndrome (MetS), but all the definitions agree that obesity, insulin resistance, dyslipidemia and hypertension are core components of this syndrome. The MetS is associated with an increased risk of cardiovascular disease events in general populations. Well-designed prospective studies in Asian populations are very limited. This study characterizes nine parameters of the MetS in a population of diabetic patients without a history of cardiovascular disease in Bangladesh, and defines the influence of MetS on peripheral vascular disease. A total of 100 patients with diabetes who visited the outpatient department of BIRDEM for routine diabetic follow-up were included in this study. The prevalence of MetS was 66%. Sixty-seven percent of patients had a waist circumference above normal, 89% hypertriglyceridemia, and 87% a low HDL-C level, while elevated systolic blood pressure was found in 46% and diastolic blood pressure in 55%, according to IDF criteria. Peripheral vascular disease defined by a low ankle-brachial index (<0.9) was identified in 24% of patients with no history of a cardiovascular event.

代谢综合征(MetS)的鉴别标准存在分歧,但所有定义都一致认为肥胖、胰岛素抵抗、血脂异常和高血压是该综合征的核心组成部分。在一般人群中,MetS与心血管疾病事件的风险增加有关。在亚洲人群中精心设计的前瞻性研究非常有限。本研究描述了孟加拉国无心血管病史的糖尿病患者人群中MetS的9个参数,并定义了MetS对周围血管疾病的影响。本研究共纳入100例到BIRDEM门诊进行糖尿病常规随访的糖尿病患者。met的患病率为66%。根据IDF标准,67%的患者腰围高于正常,89%的患者有高甘油三酯血症,87%的患者有低HDL-C水平,46%的患者有收缩压升高,55%的患者有舒张压升高。24%无心血管事件史的患者外周血管疾病定义为低踝肱指数(<0.9)。
{"title":"Metabolic syndrome and cardiovascular risk in diabetic subjects","authors":"Faria Afsana,&nbsp;Zafar A. Latif,&nbsp;Shah J. Khan,&nbsp;Samir K. Talukder","doi":"10.1016/j.cvdpc.2010.05.001","DOIUrl":"10.1016/j.cvdpc.2010.05.001","url":null,"abstract":"<div><p>There are divergent criteria for the identification of metabolic syndrome (MetS), but all the definitions agree that obesity, insulin resistance, dyslipidemia and hypertension are core components of this syndrome. The MetS is associated with an increased risk of cardiovascular disease events in general populations. Well-designed prospective studies in Asian populations are very limited. This study characterizes nine parameters of the MetS in a population of diabetic patients without a history of cardiovascular disease in Bangladesh, and defines the influence of MetS on peripheral vascular disease. A total of 100 patients with diabetes who visited the outpatient department of BIRDEM for routine diabetic follow-up were included in this study. The prevalence of MetS was 66%. Sixty-seven percent of patients had a waist circumference above normal, 89% hypertriglyceridemia, and 87% a low HDL-C level, while elevated systolic blood pressure was found in 46% and diastolic blood pressure in 55%, according to IDF criteria. Peripheral vascular disease defined by a low ankle-brachial index (&lt;0.9) was identified in 24% of patients with no history of a cardiovascular event.</p></div>","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 2","pages":"Pages 59-62"},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2010.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89334975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
In-hospital outcome of primary percutaneous coronary intervention for the management of acute ST-segment elevation myocardial infarction in a Bangladeshi population 孟加拉国人群急性st段抬高型心肌梗死的初步经皮冠状动脉介入治疗的住院结果
Pub Date : 2010-01-01 DOI: 10.1016/j.cvdpc.2010.03.002
Md. Abu Salim , Fazilatunnesa Malik , Nazir Ahmed , M. Badiuzzaman , Rumana Jesmin Khan , K.M.H.S. Sirajul Haque , Abdul Malik

Objective

This study aims to describe the different clinical outcomes of ST-Segment Elevated (STEMI) Myocardial Infarction patients of a tertiary care cardiac hospital in Bangladesh who went through Primary Per-cutaneous Coronary Intervention (PCI).

Methods

This study was conducted in the Department of Cardiology, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh. Participants of the study were 80 patients with a diagnosis of acute STEMI. Information was collected on their demographic characteristics and clinical history. Relevant physical examination and laboratory investigations were performed. Percutaneous transluminal coronary angioplasty (PTCA) ± stent implantation was done in the culprit vessel. Coronary angiograms were done before and after the procedure. They were followed up thoroughly during the hospital stay.

Results

According to the 12 lead surface ECG, 25% had an extensive anterior MI, 20% anteroseptal MI, 35% an inferior MI, 10% an anterior MI, 7.5% an inferior with right ventricular infarction and 2.5% a lateral MI. The mean door to balloon time was 95.6 ± 33.4 min. LAD was the most common (51.2%) culprit vessel followed by RCA (38.5%) and LCX (10.2%).We compare, (1) ECG changes (return of ST segment towards isoelectric line in mm). (2) Improvement of TIMI flow. (3) Improvement of LV function (LVEF measured by echocardiography). (4) Complications (general, vascular). There was significant improvement in ECG changes (return of ST segment towards isoelectric line in mm). Pre and post-procedural mean ST elevation was 6.6 ± 2.7 mm and 0.5 ± 0.8 mm. Examining improvement of TIMI flow after the PCI, 87.5% had TIMI-3 flow, 7.5% had TIMI-2 flow, 2.5% had TIMI-1 and 2.5% had TIMI-0 flow (P < 0.001). The pre-procedural mean left ventricular ejection fraction (LVEF) was 41.6 ± 4.2% and the post-procedural mean LVEF was 51.8 ± 5.1% (P < 0.01). There were, 7.7% with post-procedural general complications and no vascular complications in any of the patients. In-terms of major adverse cardiac events (MACE), only 2(2.5%) patients died, one was due to a cardiac arrest 8 h after the procedure, and another was due to ventricular fibrillation followed by asystole 2 h after the procedure.

Conclusion

The study results show that with limited facilities and financial abilities, patients receiving Primary PCI had good in hospital outcomes which is similar to other studies done in different countries. So primary PCI may be the preferred method of reperfusion for the management of STEMI in the current Bangladeshi setting.

目的本研究旨在描述孟加拉国一家三级心脏医院st段抬高型(STEMI)心肌梗死患者接受初级经皮冠状动脉介入治疗(PCI)的不同临床结果。方法本研究在孟加拉国首都达卡国立心脏基金会医院和研究所心内科进行。该研究的参与者是80名诊断为急性STEMI的患者。收集他们的人口学特征和临床病史。进行了相关的体格检查和实验室调查。经皮冠状动脉腔内成形术(PTCA) +冠脉支架置入术。手术前后分别做了冠状动脉造影。他们在住院期间得到了彻底的随访。结果12导联体表心电图显示,25%为广泛前路心肌梗死,20%为房间隔心肌梗死,35%为下路心肌梗死,10%为前路心肌梗死,7.5%为下路合并右室梗死,2.5%为侧路心肌梗死,平均门至球囊时间为95.6±33.4 min。LAD是最常见的罪魁血管(51.2%),其次是RCA(38.5%)和LCX(10.2%)。我们比较:(1)心电图变化(ST段向等电线返回,单位为mm)。(2)改善TIMI流程。(3)左室功能改善(超声心动图测量LVEF)。(4)并发症(一般、血管)。心电图变化(ST段向mm等电线返回)有明显改善。术前和术后平均ST段抬高分别为6.6±2.7 mm和0.5±0.8 mm。检查PCI术后TIMI血流改善情况,87.5%的患者TIMI-3血流,7.5%的患者TIMI-2血流,2.5%的患者TIMI-1血流,2.5%的患者TIMI-0血流(P <0.001)。术前平均左室射血分数(LVEF)为41.6±4.2%,术后平均LVEF为51.8±5.1% (P <0.01)。7.7%的患者出现术后一般并发症,无血管并发症。在主要心脏不良事件(MACE)方面,只有2例(2.5%)患者死亡,1例是由于手术后8小时心脏骤停,另1例是由于心室颤动,术后2小时心脏骤停。结论本研究结果表明,在设备和经济能力有限的情况下,接受初级PCI治疗的患者具有良好的住院效果,这与其他国家的研究结果相似。因此,在目前孟加拉国的情况下,初级PCI可能是治疗STEMI的首选再灌注方法。
{"title":"In-hospital outcome of primary percutaneous coronary intervention for the management of acute ST-segment elevation myocardial infarction in a Bangladeshi population","authors":"Md. Abu Salim ,&nbsp;Fazilatunnesa Malik ,&nbsp;Nazir Ahmed ,&nbsp;M. Badiuzzaman ,&nbsp;Rumana Jesmin Khan ,&nbsp;K.M.H.S. Sirajul Haque ,&nbsp;Abdul Malik","doi":"10.1016/j.cvdpc.2010.03.002","DOIUrl":"https://doi.org/10.1016/j.cvdpc.2010.03.002","url":null,"abstract":"<div><h3>Objective</h3><p>This study aims to describe the different clinical outcomes of ST-Segment Elevated (STEMI) Myocardial Infarction patients of a tertiary care cardiac hospital in Bangladesh who went through Primary Per-cutaneous Coronary Intervention (PCI).</p></div><div><h3>Methods</h3><p>This study was conducted in the Department of Cardiology, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh. Participants of the study were 80 patients with a diagnosis of acute STEMI. Information was collected on their demographic characteristics and clinical history. Relevant physical examination and laboratory investigations were performed. Percutaneous transluminal coronary angioplasty (PTCA)<!--> <!-->±<!--> <!-->stent implantation was done in the culprit vessel. Coronary angiograms were done before and after the procedure. They were followed up thoroughly during the hospital stay.</p></div><div><h3>Results</h3><p>According to the 12 lead surface ECG, 25% had an extensive anterior MI, 20% anteroseptal MI, 35% an inferior MI, 10% an anterior MI, 7.5% an inferior with right ventricular infarction and 2.5% a lateral MI. The mean door to balloon time was 95.6<!--> <!-->±<!--> <!-->33.4<!--> <!-->min. LAD was the most common (51.2%) culprit vessel followed by RCA (38.5%) and LCX (10.2%).We compare, (1) ECG changes (return of ST segment towards isoelectric line in mm). (2) Improvement of TIMI flow. (3) Improvement of LV function (LVEF measured by echocardiography). (4) Complications (general, vascular). There was significant improvement in ECG changes (return of ST segment towards isoelectric line in mm). Pre and post-procedural mean ST elevation was 6.6<!--> <!-->±<!--> <!-->2.7<!--> <!-->mm and 0.5<!--> <!-->±<!--> <!-->0.8<!--> <!-->mm. Examining improvement of TIMI flow after the PCI, 87.5% had TIMI-3 flow, 7.5% had TIMI-2 flow, 2.5% had TIMI-1 and 2.5% had TIMI-0 flow (<em>P</em> <!-->&lt;<!--> <!-->0.001). The pre-procedural mean left ventricular ejection fraction (LVEF) was 41.6<!--> <!-->±<!--> <!-->4.2% and the post-procedural mean LVEF was 51.8<!--> <!-->±<!--> <!-->5.1% (<em>P</em> <!-->&lt;<!--> <!-->0.01). There were, 7.7% with post-procedural general complications and no vascular complications in any of the patients. In-terms of major adverse cardiac events (MACE), only 2(2.5%) patients died, one was due to a cardiac arrest 8<!--> <!-->h after the procedure, and another was due to ventricular fibrillation followed by asystole 2<!--> <!-->h after the procedure.</p></div><div><h3>Conclusion</h3><p>The study results show that with limited facilities and financial abilities, patients receiving Primary PCI had good in hospital outcomes which is similar to other studies done in different countries. So primary PCI may be the preferred method of reperfusion for the management of STEMI in the current Bangladeshi setting.</p></div>","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 1","pages":"Pages 23-26"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2010.03.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91777271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Asian-Pacific Congress of Cardiology (APCC) – From birth to the present 亚太心脏病学大会(APCC) -从出生到现在
Pub Date : 2010-01-01 DOI: 10.1016/j.cvdpc.2010.03.001
Chuichi Kawai M.D.
{"title":"Asian-Pacific Congress of Cardiology (APCC) – From birth to the present","authors":"Chuichi Kawai M.D.","doi":"10.1016/j.cvdpc.2010.03.001","DOIUrl":"https://doi.org/10.1016/j.cvdpc.2010.03.001","url":null,"abstract":"","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 1","pages":"Pages 15-22"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2010.03.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90130472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
γ-Glutamyltransferase and mortality risk from heart disease and stroke in Japanese men and women: NIPPON DATA90 γ-谷氨酰转移酶与日本男性和女性心脏病和中风的死亡率风险:NIPPON数据90
Pub Date : 2010-01-01 DOI: 10.1016/J.CVDPC.2010.03.003
A. Fujiyoshi, K. Miura, A. Hozawa, Y. Murakami, N. Takashima, N. Okuda, T. Kadowaki, Y. Kita, T. Okamura, Yasuyuki Nakamura, T. Hayakawa, A. Okayama, H. Ueshima
{"title":"γ-Glutamyltransferase and mortality risk from heart disease and stroke in Japanese men and women: NIPPON DATA90","authors":"A. Fujiyoshi, K. Miura, A. Hozawa, Y. Murakami, N. Takashima, N. Okuda, T. Kadowaki, Y. Kita, T. Okamura, Yasuyuki Nakamura, T. Hayakawa, A. Okayama, H. Ueshima","doi":"10.1016/J.CVDPC.2010.03.003","DOIUrl":"https://doi.org/10.1016/J.CVDPC.2010.03.003","url":null,"abstract":"","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 1","pages":"27-34"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78468202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
γ-Glutamyltransferase and mortality risk from heart disease and stroke in Japanese men and women: NIPPON DATA90 γ-谷氨酰转移酶与日本男性和女性心脏病和中风的死亡率风险:NIPPON数据90
Pub Date : 2010-01-01 DOI: 10.1016/j.cvdpc.2010.03.003
Akira Fujiyoshi , Katsuyuki Miura , Atsushi Hozawa , Yoshitaka Murakami , Naoyuki Takashima , Nagako Okuda , Takashi Kadowaki , Yoshikuni Kita , Tomonori Okamura , Yasuyuki Nakamura , Takehito Hayakawa , Akira Okayama , Hirotsugu Ueshima , for the NIPPON DATA80/90 Research Group

Background

Studies have shown that baseline serum γ-glutamyltransferase (GGT) is independently associated with cardiovascular disease (CVD) risk in men and women. However, less is known whether GGT is similarly associated with both stroke and heart disease (HD) risk in Asia. We examined an association between serum GGT and deaths from stroke and HD in Japanese men and women.

Methods

From 1990 to 2005, we followed 7488 adults (3089 men) randomly selected from 300 districts throughout Japan, aged 30–95 with no history of coronary disease nor stroke at baseline. Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs) according to sex-specific GGT strata.

Results

During the study period, observed deaths from HD and stroke were 165 (83 men), and 135 (66 men), respectively. After adjustment for confounding factors, HRs of HD death for 25th, 50th, 75th, and 90th GGT percentiles in reference to the lowest GGT stratum were 1.61, 2.28, 2.48, and 4.59 in women (P for trend = 0.001), and 0.90, 0.74, 1.42, and 1.56 in men (P for trend = 0.250). The corresponding HRs of total stroke death were 1.52, 0.95, 1.22, and 1.34 in women (P for trend = 0.785), and 0.75, 0.91, 1.26, and 1.02 in men (P for trend = 0.642). Results were similar when analysis was limited to never-drinkers.

Conclusion

This cohort study of representative Japanese men and women suggested that baseline GGT independently predicts future HD mortality risk, especially in women, but not stroke mortality risk in Asian.

研究表明,基线血清γ-谷氨酰转移酶(GGT)与男性和女性心血管疾病(CVD)风险独立相关。然而,在亚洲,GGT是否同样与中风和心脏病(HD)风险相关尚不清楚。我们研究了血清GGT与日本男性和女性中风和HD死亡之间的关系。方法从1990年到2005年,我们从日本300个地区随机选择了7488名成年人(其中3089名男性),年龄在30-95岁之间,基线时无冠心病和卒中史。采用Cox比例风险模型估计不同性别GGT层的调整风险比(hr)。结果在研究期间,观察到的HD和中风死亡人数分别为165人(83名男性)和135人(66名男性)。校正混杂因素后,与最低GGT层相关的第25、50、75和90 GGT百分位数的HD死亡hr在女性中分别为1.61、2.28、2.48和4.59(趋势P = 0.001),在男性中分别为0.90、0.74、1.42和1.56(趋势P = 0.250)。女性卒中总死亡的相应hr分别为1.52、0.95、1.22和1.34 (P = 0.785),男性为0.75、0.91、1.26和1.02 (P = 0.642)。当分析仅限于从不饮酒者时,结果相似。这项针对日本男性和女性的队列研究表明,基线GGT独立预测未来HD死亡风险,尤其是女性,但不能预测亚洲人中风死亡风险。
{"title":"γ-Glutamyltransferase and mortality risk from heart disease and stroke in Japanese men and women: NIPPON DATA90","authors":"Akira Fujiyoshi ,&nbsp;Katsuyuki Miura ,&nbsp;Atsushi Hozawa ,&nbsp;Yoshitaka Murakami ,&nbsp;Naoyuki Takashima ,&nbsp;Nagako Okuda ,&nbsp;Takashi Kadowaki ,&nbsp;Yoshikuni Kita ,&nbsp;Tomonori Okamura ,&nbsp;Yasuyuki Nakamura ,&nbsp;Takehito Hayakawa ,&nbsp;Akira Okayama ,&nbsp;Hirotsugu Ueshima ,&nbsp;for the NIPPON DATA80/90 Research Group","doi":"10.1016/j.cvdpc.2010.03.003","DOIUrl":"https://doi.org/10.1016/j.cvdpc.2010.03.003","url":null,"abstract":"<div><h3>Background</h3><p>Studies have shown that baseline serum γ-glutamyltransferase (GGT) is independently associated with cardiovascular disease (CVD) risk in men and women. However, less is known whether GGT is similarly associated with both stroke and heart disease (HD) risk in Asia. We examined an association between serum GGT and deaths from stroke and HD in Japanese men and women.</p></div><div><h3>Methods</h3><p>From 1990 to 2005, we followed 7488 adults (3089 men) randomly selected from 300 districts throughout Japan, aged 30–95 with no history of coronary disease nor stroke at baseline. Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs) according to sex-specific GGT strata.</p></div><div><h3>Results</h3><p>During the study period, observed deaths from HD and stroke were 165 (83 men), and 135 (66 men), respectively. After adjustment for confounding factors, HRs of HD death for 25th, 50th, 75th, and 90th GGT percentiles in reference to the lowest GGT stratum were 1.61, 2.28, 2.48, and 4.59 in women (<em>P</em> for trend<!--> <!-->=<!--> <!-->0.001), and 0.90, 0.74, 1.42, and 1.56 in men (<em>P</em> for trend<!--> <!-->=<!--> <!-->0.250). The corresponding HRs of total stroke death were 1.52, 0.95, 1.22, and 1.34 in women (<em>P</em> for trend<!--> <!-->=<!--> <!-->0.785), and 0.75, 0.91, 1.26, and 1.02 in men (<em>P</em> for trend<!--> <!-->=<!--> <!-->0.642). Results were similar when analysis was limited to never-drinkers.</p></div><div><h3>Conclusion</h3><p>This cohort study of representative Japanese men and women suggested that baseline GGT independently predicts future HD mortality risk, especially in women, but not stroke mortality risk in Asian.</p></div>","PeriodicalId":11021,"journal":{"name":"Cvd Prevention and Control","volume":"5 1","pages":"Pages 27-34"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cvdpc.2010.03.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91777270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
Cvd Prevention and Control
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1